N-PX 1 a15-15355_2npx.htm N-PX

 

 

 

UNITED STATES

OMB APPROVAL

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

OMB Number:  3235-0582

 

Expires:  March 31, 2018

 

Estimated average burden hours per response........7.2

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number  811- 06565

 

Tekla Life Sciences Investors

(Exact name of registrant as specified in charter)

 

100 Federal Street, 19th Floor, Boston, MA

 

02110

(Address of principal executive offices)

 

(Zip code)

 

Laura Woodward
Tekla Life Sciences Investors
100 Federal Street, 19th Floor, Boston MA 02110

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:  617-772-8500

 

Date of fiscal year end:  September 30

 

Date of reporting period:  7/1/14-6/30/15

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss. 239.24 and 274.5 of this chapter), to file reports with the Commission, no later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4).  The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.  A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number.  Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC  20549-0609.  The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.

 

 

 


 

Item 1. Proxy Voting Record.

 


 

Vote Summary

 

ACADIA PHARMACEUTICALS INC.

 

Security

 

004225108

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ACAD

 

 

 

Meeting Date

 

15-Jun-2015

Record Date

 

16-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

STEPHEN BIGGAR

 

 

 

For

 

For

 

 

 

2

TORSTEN RASMUSSEN

 

 

 

For

 

For

 

 

 

3

DANIEL SOLAND

 

 

 

For

 

For

 

2.

 

TO APPROVE AN AMENDMENT TO OUR 2010 EQUITY INCENTIVE PLAN, AS AMENDED, TO, AMONG OTHER THINGS, INCREASE THE AGGREGATE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 5,000,000 SHARES.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO OUR AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 150,000,000 TO 225,000,000.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, OUR EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

5.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

 


 

ACCELERATE DIAGNOSTICS, INC.

 

Security

 

00430H102

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

AXDX

 

 

 

Meeting Date

 

13-May-2015

Record Date

 

19-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

LAWRENCE MEHREN

 

 

 

For

 

For

 

 

 

2

MARK MILLER

 

 

 

For

 

For

 

 

 

3

JOHN PATIENCE

 

 

 

For

 

For

 

 

 

4

JACK SCHULER

 

 

 

For

 

For

 

 

 

5

MATTHEW STROBECK, PH.D.

 

 

 

For

 

For

 

 

 

6

FRANK J.M. TEN BRINK

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE INDEPENDENT PUBLIC ACCOUNTANTS OF THE COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015

 

Management

 

For

 

For

 

 

ACCURAY INCORPORATED

 

Security

 

004397105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ARAY

 

 

 

Meeting Date

 

20-Nov-2014

Record Date

 

26-Sep-2014

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: LOUIS J. LAVIGNE, JR.

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: DENNIS L. WINGER

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: JACK GOLDSTEIN, PH.D.

 

Management

 

For

 

For

 

2.

 

ADVISORY VOTE ON THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS (SAY-ON-PAY VOTE).

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF GRANT THORNTON LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2015.

 

Management

 

For

 

For

 

 


 

ACORDA THERAPEUTICS, INC.

 

Security

 

00484M106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ACOR

 

 

 

Meeting Date

 

09-Jun-2015

Record Date

 

13-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

BARRY GREENE

 

 

 

For

 

For

 

 

 

2

IAN SMITH

 

 

 

For

 

For

 

2.

 

TO APPROVE THE ACORDA THERAPEUTICS, INC. 2015 OMNIBUS INCENTIVE COMPENSATION PLAN

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015

 

Management

 

For

 

For

 

4.

 

AN ADVISORY VOTE TO APPROVE NAMED EXECUTIVE OFFICER COMPENSATION

 

Management

 

For

 

For

 

 

ACTAVIS PLC

 

Security

 

G0083B108

 

 

 

Meeting Type

 

Special

Ticker Symbol

 

ACT

 

 

 

Meeting Date

 

10-Mar-2015

Record Date

 

22-Jan-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

APPROVING THE ISSUANCE OF ORDINARY SHARES PURSUANT TO THE AGREEMENT AND PLAN OF MERGER, DATED NOVEMBER 16, 2014, AMONG ACTAVIS PLC (“ACTAVIS”), AVOCADO ACQUISITION INC. AND ALLERGAN, INC. (THE “ACTAVIS SHARE ISSUANCE PROPOSAL”).

 

Management

 

For

 

For

 

2.

 

APPROVING ANY MOTION TO ADJOURN THE ACTAVIS EXTRAORDINARY GENERAL MEETING (THE “ACTAVIS EGM”), OR ANY ADJOURNMENTS THEREOF, TO ANOTHER TIME OR PLACE IF NECESSARY OR APPROPRIATE TO, AMONG OTHER THINGS, SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES AT THE TIME OF THE ACTAVIS EGM TO APPROVE THE ACTAVIS SHARE ISSUANCE PROPOSAL.

 

Management

 

For

 

For

 

 


 

ACTAVIS PLC

 

Security

 

G0083B108

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ACT

 

 

 

Meeting Date

 

05-Jun-2015

Record Date

 

10-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: PAUL M. BISARO

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: NESLI BASGOZ, M.D.

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: JAMES H. BLOEM

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: CHRISTOPHER W. BODINE

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: CHRISTOPHER J. COUGHLIN

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: MICHAEL R. GALLAGHER

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: CATHERINE M. KLEMA

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: PETER J. MCDONNELL, M.D.

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: PATRICK J. O’SULLIVAN

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: BRENTON L. SAUNDERS

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: RONALD R. TAYLOR

 

Management

 

For

 

For

 

1L.

 

ELECTION OF DIRECTOR: FRED G. WEISS

 

Management

 

For

 

For

 

2.

 

TO APPROVE, IN A NON-BINDING VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

3.

 

TO RATIFY, IN A NON-BINDING VOTE, THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015 AND TO AUTHORIZE, IN A BINDING VOTE, THE BOARD OF DIRECTORS, ACTING THROUGH THE AUDIT AND COMPLIANCE COMMITTEE, TO DETERMINE PRICEWATERHOUSECOOPERS LLP’S REMUNERATION.

 

Management

 

For

 

For

 

4.

 

TO PASS A SPECIAL RESOLUTION TO APPROVE, SUBJECT TO THE APPROVAL OF THE REGISTRAR OF COMPANIES IN IRELAND, THE CHANGE IN NAME OF THE COMPANY FROM ACTAVIS PLC TO ALLERGAN PLC.

 

Management

 

For

 

For

 

5.

 

TO APPROVE THE AMENDED AND RESTATED 2013 INCENTIVE AWARD PLAN OF ACTAVIS PLC.

 

Management

 

For

 

For

 

6.

 

TO VOTE ON A SHAREHOLDER PROPOSAL REQUESTING THE COMPANY TO ISSUE A SUSTAINABILITY REPORT.

 

Shareholder

 

Against

 

For

 

7.

 

TO VOTE ON A SHAREHOLDER PROPOSAL REQUESTING THE COMPANY TO ADOPT SUCH SHAREHOLDER’S POLICY REGARDING EXECUTIVE STOCK RETENTION.

 

Shareholder

 

Against

 

For

 

 


 

ALEXION PHARMACEUTICALS, INC.

 

Security

 

015351109

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ALXN

 

 

 

Meeting Date

 

06-May-2015

Record Date

 

13-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: LEONARD BELL

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: DAVID R. BRENNAN

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: M. MICHELE BURNS

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: CHRISTOPHER J. COUGHLIN

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: DAVID L. HALLAL

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: JOHN T. MOLLEN

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: R. DOUGLAS NORBY

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: ALVIN S. PARVEN

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: ANDREAS RUMMELT

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: ANN M. VENEMAN

 

Management

 

For

 

For

 

2.

 

APPROVAL OF A NON-BINDING ADVISORY VOTE OF THE 2014 COMPENSATION PAID TO ALEXION’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

RATIFICATION OF APPOINTMENT BY THE BOARD OF DIRECTORS OF PRICEWATERHOUSECOOPERS LLP AS ALEXION’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

Management

 

For

 

For

 

4.

 

TO APPROVE ALEXION’S 2015 EMPLOYEE STOCK PURCHASE PLAN.

 

Management

 

For

 

For

 

5.

 

TO REQUEST THE BOARD TO AMEND ALEXION’S GOVERNING DOCUMENTS TO ALLOW PROXY ACCESS.

 

Shareholder

 

Against

 

For

 

6.

 

TO REQUEST THE BOARD TO AMEND ALEXION’S GOVERNING DOCUMENTS TO GIVE SHAREHOLDERS OWNING 10% OF ALEXION STOCK THE POWER TO CALL A SPECIAL MEETING.

 

Shareholder

 

Against

 

For

 

 


 

ALKERMES PLC

 

Security

 

G01767105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ALKS

 

 

 

Meeting Date

 

27-May-2015

Record Date

 

17-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: FLOYD E. BLOOM

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: NANCY J. WYSENSKI

 

Management

 

For

 

For

 

2.

 

TO HOLD A NON-BINDING, ADVISORY VOTE TO APPROVE THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO AUTHORIZE HOLDING THE 2016 ANNUAL GENERAL MEETING OF SHAREHOLDERS OF THE COMPANY AT A LOCATION OUTSIDE OF IRELAND.

 

Management

 

For

 

For

 

4.

 

TO APPOINT PRICEWATERHOUSECOOPERS LLP AS THE INDEPENDENT ACCOUNTING FIRM OF THE COMPANY AND TO AUTHORIZE THE AUDIT AND RISK COMMITTEE OF THE BOARD OF DIRECTORS TO SET THE ACCOUNTING FIRM’S REMUNERATION.

 

Management

 

For

 

For

 

 

ALNYLAM PHARMACEUTICALS, INC.

 

Security

 

02043Q107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ALNY

 

 

 

Meeting Date

 

25-Sep-2014

Record Date

 

15-Aug-2014

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOHN M. MARAGANORE

 

 

 

For

 

For

 

 

 

2

PAUL R. SCHIMMEL

 

 

 

For

 

For

 

 

 

3

PHILLIP A. SHARP

 

 

 

For

 

For

 

2.

 

TO APPROVE, IN A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF ALNYLAM’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS ALNYLAM’S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

 


 

ALNYLAM PHARMACEUTICALS, INC.

 

Security

 

02043Q107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ALNY

 

 

 

Meeting Date

 

01-May-2015

Record Date

 

04-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DENNIS A. AUSIELLO, M.D

 

 

 

For

 

For

 

 

 

2

JOHN K. CLARKE

 

 

 

For

 

For

 

 

 

3

MARSHA H. FANUCCI

 

 

 

For

 

For

 

2.

 

TO APPROVE THE AMENDED AND RESTATED 2009 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, IN A NON-BINDING ADVISORY VOTE, THE COMPENSATION OF ALNYLAM’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS ALNYLAM’S INDEPENDENT AUDITORS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

 

AMGEN INC.

 

Security

 

031162100

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

AMGN

 

 

 

Meeting Date

 

14-May-2015

Record Date

 

16-Mar-2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: DR. DAVID BALTIMORE

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: MR. FRANK J. BIONDI, JR.

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: MR. ROBERT A. BRADWAY

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: MR. FRANCOIS DE CARBONNEL

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: DR. VANCE D. COFFMAN

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: MR. ROBERT A. ECKERT

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: MR. GREG C. GARLAND

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: DR. REBECCA M. HENDERSON

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: MR. FRANK C. HERRINGER

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: DR. TYLER JACKS

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: MS. JUDITH C. PELHAM

 

Management

 

For

 

For

 

1L.

 

ELECTION OF DIRECTOR: DR. RONALD D. SUGAR

 

Management

 

For

 

For

 

1M.

 

ELECTION OF DIRECTOR: DR. R. SANDERS WILLIAMS

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

ADVISORY VOTE TO APPROVE OUR EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

4.

 

STOCKHOLDER PROPOSAL (VOTE TABULATION).

 

Shareholder

 

Against

 

For

 

 


 

BELLICUM PHARMACEUTICALS INC

 

Security

 

079481107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

BLCM

 

 

 

Meeting Date

 

17-Jun-2015

Record Date

 

20-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

FRANK B. MCGUYER

 

 

 

For

 

For

 

 

 

2

JON P. STONEHOUSE

 

 

 

For

 

For

 

2.

 

RATIFICATION OF SELECTION OF ERNST & YOUNG LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

 

BIODELIVERY SCIENCES INTERNATIONAL, INC.

 

Security

 

09060J106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

BDSI

 

 

 

Meeting Date

 

17-Jul-2014

Record Date

 

09-Jun-2014

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

WILLIAM B. STONE

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT BY THE AUDIT COMMITTEE OF THE COMPANY’S BOARD OF DIRECTORS OF CHERRY BEKAERT LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2014.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S 2011 EQUITY INCENTIVE PLAN TO, AMONG OTHER MATTERS, INCREASE THE NUMBER OF SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE UNDER THE 2011 PLAN FROM 6,800,000 TO 8,800,000.

 

Management

 

For

 

For

 

4.

 

IN THEIR DISCRETION, UPON THE TRANSACTION OF ANY OTHER MATTERS WHICH MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENT THEREOF.

 

Management

 

For

 

For

 

 


 

BIOGEN INC.

 

Security

 

09062X103

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

BIIB

 

 

 

Meeting Date

 

10-Jun-2015

Record Date

 

15-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: ALEXANDER J. DENNER

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: CAROLINE D. DORSA

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: NANCY L. LEAMING

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: RICHARD C. MULLIGAN

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: ROBERT W. PANGIA

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: STELIOS PAPADOPOULOS

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: BRIAN S. POSNER

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: ERIC K. ROWINSKY

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: GEORGE A. SCANGOS

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: LYNN SCHENK

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: STEPHEN A. SHERWIN

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS BIOGEN INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.

 

Management

 

For

 

For

 

3.

 

SAY ON PAY - AN ADVISORY VOTE ON EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE BIOGEN INC. 2015 EMPLOYEE STOCK PURCHASE PLAN.

 

Management

 

For

 

For

 

5.

 

TO APPROVE AN AMENDMENT TO THE BIOGEN INC. 2006 NON-EMPLOYEE DIRECTORS EQUITY PLAN.

 

Management

 

For

 

For

 

 


 

BIOMARIN PHARMACEUTICAL INC.

 

Security

 

09061G101

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

BMRN

 

 

 

Meeting Date

 

09-Jun-2015

Record Date

 

10-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JEAN-JACQUES BIENAIME

 

 

 

For

 

For

 

 

 

2

MICHAEL GREY

 

 

 

For

 

For

 

 

 

3

ELAINE J. HERON

 

 

 

For

 

For

 

 

 

4

PIERRE LAPALME

 

 

 

For

 

For

 

 

 

5

V. BRYAN LAWLIS

 

 

 

For

 

For

 

 

 

6

RICHARD A. MEIER

 

 

 

For

 

For

 

 

 

7

ALAN J. LEWIS

 

 

 

For

 

For

 

 

 

8

WILLIAM D. YOUNG

 

 

 

For

 

For

 

 

 

9

KENNETH M. BATE

 

 

 

For

 

For

 

 

 

10

DENNIS J. SLAMON

 

 

 

For

 

For

 

2

 

TO APPROVE AN AMENDMENT TO BIOMARIN’S AMENDED AND RESTATED 2006 SHARE INCENTIVE PLAN.

 

Management

 

For

 

For

 

3

 

TO VOTE ON AN ADVISORY BASIS TO APPROVE THE COMPENSATION OF BIOMARIN’S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN ITS PROXY STATEMENT.

 

Management

 

For

 

For

 

4

 

TO RATIFY THE SELECTION OF KPMG LLP AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR BIOMARIN FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

5

 

TO VOTE UPON A STOCKHOLDER PROPOSAL RELATING TO SUSTAINABILITY REPORTING, IF PROPERLY PRESENTED AT THE MEETING.

 

Shareholder

 

Against

 

For

 

 


 

BLUEBIRD BIO INC.

 

Security

 

09609G100

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

BLUE

 

 

 

Meeting Date

 

04-Jun-2015

Record Date

 

10-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DANIEL S. LYNCH

 

 

 

For

 

For

 

 

 

2

JOHN M. MARAGANORE

 

 

 

For

 

For

 

2.

 

ADVISORY VOTE ON EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

3.

 

ADVISORY VOTE ON THE FREQUENCY OF ADVISORY VOTES ON EXECUTIVE COMPENSATION.

 

Management

 

3 Years

 

For

 

4.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

 

CARDIOKINETIX, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

13-Aug-2014

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

APPROVAL OF BRIDGE LOAN FINANCING

 

Management

 

For

 

For

 

2

 

OMNIBUS PROVISION

 

Management

 

For

 

For

 

 

CARDIOKINETIX, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

5-Dec-2014

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

APPROVAL OF THE OPTION AND OPTION TRANSACTIONS

 

Management

 

For

 

For

 

2

 

APPROVAL OF THE MERGER AND MERGER TRANSACTIONS

 

Management

 

For

 

For

 

3

 

APPOINTMENT OF STOCKHOLDER REPRESENTATIVE AND APPROVAL OF RESERVE AMOUNT

 

Management

 

For

 

For

 

4

 

WAIVER OF NOTICE PERIOD AND SHORTENING OF NOTICE PERIOD

 

Management

 

For

 

For

 

5

 

WAIVER OF APPRAISAL RIGHTS

 

Management

 

For

 

For

 

6

 

AMENDMENT AND RESTATEMENT TO CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

7

 

SALE AND ISSUANCE OF SERIES F PREFERRED STOCK AND INTERESTED PARTY TRANSACTIONS

 

Management

 

For

 

For

 

8

 

WAIVER OF RIGHT OF FIRST OFFER

 

Management

 

For

 

For

 

9

 

WAIVER OF ANTI-DILUTION ADJUSTMENTS

 

Management

 

For

 

For

 

10

 

GENERAL AUTHORIZING RESOLUTIONS

 

Management

 

For

 

For

 

 


 

CARDIOKINETIX, INC.

 

Security

 

N/A

 

 

 

Meeting Type 

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

22-Dec-2014

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

APPROVAL OF CERTAIN PAYMENTS PURSUANT TO SECTION 280G OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED

 

Management

 

For

 

For

 

 

CARDIOKINETIX, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

13-Apr-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

AMENDMENT OF 2011 EQUITY INCENTIVE PLAN

 

Management

 

For

 

For

 

2

 

APPOINTMENT OF TEKLA DIRECTOR MARK CHAREST

 

Management

 

For

 

For

 

3

 

OMNIBUS RESOLUTION

 

Management

 

For

 

For

 

 


 

CARDIOKINETIX, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

14-May-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

WAIVER OF RIGHTS OF FIRST REFUSAL AND RIGHTS OF CO-SALE

 

Management

 

For

 

For

 

2

 

ACKNOWLEDGEMENT OF TRANSFER OF RIGHTS

 

Management

 

For

 

For

 

3

 

EFFECTIVENESS

 

Management

 

For

 

For

 

 

CARDIOKINETIX, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

24-Jun-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

ENTRY INTO LEASE

 

Management

 

For

 

For

 

2

 

OMNIBUS RESOLUTION

 

Management

 

For

 

For

 

 


 

CELGENE CORPORATION

 

Security

 

151020104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

CELG

 

 

 

Meeting Date

 

17-Jun-2015

Record Date

 

20-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT J. HUGIN

 

 

 

For

 

For

 

 

 

2

R.W. BARKER, D. PHIL.

 

 

 

For

 

For

 

 

 

3

MICHAEL W. BONNEY

 

 

 

For

 

For

 

 

 

4

MICHAEL D. CASEY

 

 

 

For

 

For

 

 

 

5

CARRIE S. COX

 

 

 

For

 

For

 

 

 

6

MICHAEL A. FRIEDMAN, MD

 

 

 

For

 

For

 

 

 

7

GILLA S. KAPLAN, PH.D.

 

 

 

For

 

For

 

 

 

8

JAMES J. LOUGHLIN

 

 

 

For

 

For

 

 

 

9

ERNEST MARIO, PH.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

APPROVAL OF AN AMENDMENT AND RESTATEMENT OF THE COMPANY’S 2008 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

4.

 

APPROVAL, BY NON-BINDING VOTE, OF EXECUTIVE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

5.

 

STOCKHOLDER PROPOSAL DESCRIBED IN MORE DETAIL IN THE PROXY STATEMENT.

 

Shareholder

 

Against

 

For

 

 


 

CELLECTIS S.A.

 

Security

 

15117K103

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

CLLS

 

 

 

Meeting Date

 

18-May-2015

Record Date

 

05-May-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

O1

 

APPROVAL OF THE ANNUAL FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014

 

Management

 

For

 

For

 

O2

 

APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014

 

Management

 

For

 

For

 

O3

 

ALLOCATION OF INCOME FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014

 

Management

 

For

 

For

 

O4

 

REVIEW OF THE AGREEMENTS REFERRED TO IN ARTICLES L. 225-38 AND FOLLOWING OF THE FRENCH COMMERCIAL CODE (CODE DE COMMERCE)

 

Management

 

For

 

For

 

O5

 

REAPPOINTMENT OF MR. ANDRE CHOULIKA AS A DIRECTOR

 

Management

 

For

 

For

 

O6

 

REAPPOINTMENT OF MR. DAVID SOURDIVE AS A DIRECTOR

 

Management

 

For

 

For

 

O7

 

REAPPOINTMENT OF MR. ALAIN GODARD AS A DIRECTOR

 

Management

 

For

 

For

 

O8

 

APPOINTMENT OF A NEW DIRECTOR (MR. JEAN-MARIE MESSIER)

 

Management

 

For

 

For

 

O9

 

APPROVAL OF THE REGULATIONS PERTAINING TO THE STOCK OPTION OR STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS ON MARCH 24, 2015

 

Management

 

For

 

For

 

E10

 

AMENDMENT OF ARTICLE 18 OF THE COMPANY’S ARTICLES OF ASSOCIATION TO COMPLY WITH DECREE NO. 2014-1466 DATED DECEMBER 8, 2014.

 

Management

 

For

 

For

 

 


 

ENDO INTERNATIONAL PLC

 

Security

 

G30401106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ENDP

 

 

 

Meeting Date

 

09-Jun-2015

Record Date

 

14-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: ROGER H. KIMMEL

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: RAJIV DE SILVA

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: SHANE M. COOKE

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: ARTHUR J. HIGGINS

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: NANCY J. HUTSON, PH.D.

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: MICHAEL HYATT

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: WILLIAM P. MONTAGUE

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: JILL D. SMITH

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: WILLIAM F. SPENGLER

 

Management

 

For

 

For

 

2.

 

TO APPROVE THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT AUDITORS FOR THE YEAR ENDING DECEMBER 31, 2015 AND TO AUTHORIZE THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS TO DETERMINE THE AUDITORS’ REMUNERATION.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, BY ADVISORY VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE 2015 STOCK INCENTIVE PLAN.

 

Management

 

For

 

For

 

 

EPIZYME INC.

 

Security

 

29428V104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

EPZM

 

 

 

Meeting Date

 

19-May-2015

Record Date

 

01-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CARL GOLDFISCHER, M.D.

 

 

 

For

 

For

 

 

 

2

BETH SEIDENBERG, M.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS EPIZYME’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

 


 

FOAMIX PHARMACEUTICALS LTD

 

Security

 

M46135105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

FOMX

 

 

 

Meeting Date

 

22-Jun-2015

Record Date

 

21-May-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1A.

 

TO RATIFY THE ELECTION OF DR. ANNA KAZANCHYAN AS A DIRECTOR OF THE COMPANY

 

Management

 

For

 

For

 

1B.

 

TO RATIFY THE ELECTION OF DR. AARON SCHWARTZ AS A DIRECTOR OF THE COMPANY

 

Management

 

For

 

For

 

2.

 

TO APPOINT KESSELMAN & KESSELMAN, A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2015

 

Management

 

For

 

For

 

3.

 

TO APPROVE THE COMPANY’S EXECUTIVES AND DIRECTORS COMPENSATION POLICY

 

Management

 

For

 

For

 

4A.

 

TO GRANT DR. TAMARKIN A CASH BONUS OF NIS 459,000 FOR THE YEAR 2014

 

Management

 

For

 

For

 

4B.

 

TO INCREASE THE ANNUAL BASE SALARY OF DR. TAMARKIN, TO $290,000, EFFECTIVE JANUARY 1, 2015

 

Management

 

For

 

For

 

4C.

 

TO GRANT DR. TAMARKIN OPTIONS TO PURCHASE 45,000 ORDINARY SHARES

 

Management

 

For

 

For

 

4D.

 

TO GRANT DR. TAMARKIN 18,000 RESTRICTED STOCK UNITS OF THE COMPANY

 

Management

 

For

 

For

 

5A.

 

TO GRANT MR. EINI A CASH BONUS OF NIS 459,000 FOR THE YEAR 2014

 

Management

 

For

 

For

 

5B.

 

TO INCREASE THE ANNUAL BASE SALARY OF MR. EINI TO $283,500, EFFECTIVE JANUARY 1, 2015

 

Management

 

For

 

For

 

5C.

 

TO GRANT MR. EINI OPTIONS TO PURCHASE 36,000 ORDINARY SHARES

 

Management

 

For

 

For

 

5D.

 

TO GRANT MR. EINI 18,000 RESTRICTED STOCK UNITS OF THE COMPANY

 

Management

 

For

 

For

 

 


 

GALAPAGOS NV

 

Security

 

B4413P105

 

 

 

Meeting Type

 

MIX

Ticker Symbol

 

GLPG

 

 

 

Meeting Date

 

28-Apr-2015

Record Date

 

14-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

CMMT

 

IMPORTANT MARKET PROCESSING REQUIREMENT: A BENEFICIAL OWNER SIGNED POWER OF-ATTORNEY (POA) MAY BE REQUIRED IN ORDER TO LODGE AND EXECUTE YOUR VOTING-INSTRUCTIONS IN THIS MARKET. ABSENCE OF A POA, MAY CAUSE YOUR INSTRUCTIONS TO-BE REJECTED. IF YOU HAVE ANY QUESTIONS, PLEASE CONTACT YOUR CLIENT SERVICE-REPRESENTATIVE

 

Non-Voting

 

None

 

None

 

CMMT

 

MARKET RULES REQUIRE DISCLOSURE OF BENEFICIAL OWNER INFORMATION FOR ALL VOTED-ACCOUNTS. IF AN ACCOUNT HAS MULTIPLE BENEFICIAL OWNERS, YOU WILL NEED TO-PROVIDE THE BREAKDOWN OF EACH BENEFICIAL OWNER NAME, ADDRESS AND SHARE-POSITION TO YOUR CLIENT SERVICE REPRESENTATIVE. THIS INFORMATION IS REQUIRED-IN ORDER FOR YOUR VOTE TO BE LODGED

 

Non-Voting

 

None

 

None

 

A.1

 

RECEIVE DIRECTORS’ AND AUDITORS’ REPORTS

 

Non-Voting

 

None

 

None

 

A.2

 

APPROVE FINANCIAL STATEMENTS AND ALLOCATION OF INCOME

 

Management

 

For

 

For

 

A.3

 

RECEIVE AUDITORS’ REPORTS

 

Non-Voting

 

None

 

None

 

A.4

 

RECEIVE CONSOLIDATED FINANCIAL STATEMENTS AND STATUTORY REPORTS

 

Non-Voting

 

None

 

None

 

A.5

 

APPROVE REMUNERATION REPORT

 

Management

 

For

 

For

 

A.6

 

APPROVE DISCHARGE OF DIRECTORS AND AUDITORS

 

Management

 

For

 

For

 

A.7

 

REELECT DELOITTE AS AUDITOR AND APPROVE AUDITOR’S REMUNERATION

 

Management

 

For

 

For

 

A.8

 

APPROVE REMUNERATION OF DIRECTORS

 

Management

 

For

 

For

 

A.9

 

APPROVE GALAPAGOS WARRANT PLAN 2015

 

Management

 

For

 

For

 

S.10

 

APPROVE CHANGE-OF-CONTROL CLAUSES

 

Management

 

For

 

For

 

S.11

 

TRANSACT OTHER BUSINESS

 

Non-Voting

 

None

 

None

 

 


 

GILEAD SCIENCES, INC.

 

Security

 

375558103

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

GILD

 

 

 

Meeting Date

 

06-May-2015

Record Date

 

11-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: JOHN F. COGAN

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: ETIENNE F. DAVIGNON

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: CARLA A. HILLS

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: KEVIN E. LOFTON

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: JOHN W. MADIGAN

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: JOHN C. MARTIN

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: NICHOLAS G. MOORE

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: RICHARD J. WHITLEY

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: GAYLE E. WILSON

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: PER WOLD-OLSEN

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP BY THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF GILEAD FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT AND RESTATEMENT TO GILEAD’S EMPLOYEE STOCK PURCHASE PLAN AND INTERNATIONAL EMPLOYEE STOCK PURCHASE PLAN.

 

Management

 

For

 

For

 

4.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS PRESENTED IN THE PROXY STATEMENT.

 

Management

 

For

 

For

 

5.

 

TO VOTE ON A STOCKHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT THE BOARD TAKE STEPS TO PERMIT STOCKHOLDER ACTION BY WRITTEN CONSENT.

 

Shareholder

 

Against

 

For

 

6.

 

TO VOTE ON A STOCKHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT THE BOARD ADOPT A POLICY THAT THE CHAIRMAN OF THE BOARD OF DIRECTORS BE AN INDEPENDENT DIRECTOR.

 

Shareholder

 

Against

 

For

 

7.

 

TO VOTE ON A STOCKHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT GILEAD ISSUE AN ANNUAL SUSTAINABILITY REPORT.

 

Shareholder

 

Against

 

For

 

8.

 

TO VOTE ON A STOCKHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING THAT THE BOARD REPORT ON CERTAIN RISKS TO GILEAD FROM RISING PRESSURE TO CONTAIN U.S. SPECIALTY DRUG PRICES.

 

Shareholder

 

Against

 

For

 

 


 

HERON THERAPEUTICS INC.

 

Security

 

427746102

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

HRTX

 

 

 

Meeting Date

 

09-Jun-2015

Record Date

 

15-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

KEVIN C. TANG

 

 

 

For

 

For

 

 

 

2

BARRY D. QUART, PHARM D

 

 

 

For

 

For

 

 

 

3

ROBERT H. ROSEN

 

 

 

For

 

For

 

 

 

4

CRAIG A. JOHNSON

 

 

 

For

 

For

 

 

 

5

KIMBERLY J. MANHARD

 

 

 

For

 

For

 

 

 

6

JOHN W. POYHONEN

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF OUM & CO. LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

TO CONDUCT AN ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS DURING FISCAL YEAR 2014.

 

Management

 

For

 

For

 

4.

 

TO AMEND THE COMPANY’S 2007 AMENDED AND RESTATED EQUITY INCENTIVE PLAN TO INCREASE THE SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE THEREUNDER BY 4,300,000 SHARES.

 

Management

 

Against

 

Against

 

5.

 

TO AMEND THE COMPANY’S 1997 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED, TO INCREASE THE SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE THEREUNDER BY 100,000 SHARES.

 

Management

 

Against

 

Against

 

 


 

IDEXX LABORATORIES, INC.

 

Security

 

45168D104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

IDXX

 

 

 

Meeting Date

 

06-May-2015

Record Date

 

10-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

WILLIAM T. END

 

 

 

For

 

For

 

 

 

2

BARRY C. JOHNSON, PHD

 

 

 

For

 

For

 

 

 

3

DANIEL M. JUNIUS

 

 

 

For

 

For

 

2

 

ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION. TO APPROVE A NONBINDING ADVISORY RESOLUTION ON THE COMPANY’S EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

3

 

AMENDMENTS TO IDEXX LABORATORIES, INC. 1997 EMPLOYEE STOCK PURCHASE PLAN. TO APPROVE PROPOSED AMENDMENTS TO THE COMPANY’S 1997 EMPLOYEE STOCK PURCHASE PLAN.

 

Management

 

For

 

For

 

4

 

RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE CURRENT FISCAL YEAR.

 

Management

 

For

 

For

 

 


 

ILLUMINA, INC.

 

Security

 

452327109

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ILMN

 

 

 

Meeting Date

 

27-May-2015

Record Date

 

31-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: A. BLAINE BOWMAN

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: KARIN EASTHAM, CPA

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: JAY T. FLATLEY

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: JEFFREY T. HUBER

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: WILLIAM H. RASTETTER, PH.D.

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JANUARY 3, 2016

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THE PROXY STATEMENT

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE ILLUMINA, INC. 2015 STOCK AND INCENTIVE PLAN

 

Management

 

For

 

For

 

 

ILLUMINOSS MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

25-Nov-2014

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

CONSENT TO TRANCHE CLOSING

 

Management

 

For

 

For

 

 

ILLUMINOSS MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

17-Mar-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

CONSENT TO TRANCHE CLOSING

 

Management

 

For

 

For

 

 


 

IMPAX LABORATORIES, INC.

 

Security

 

45256B101

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

IPXL

 

 

 

Meeting Date

 

12-May-2015

Record Date

 

06-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: LESLIE Z. BENET, PH.D.

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: ROBERT L. BURR

 

Management

 

For

 

For

 

1.3

 

ELECTION OF DIRECTOR: ALLEN CHAO, PH.D.

 

Management

 

For

 

For

 

1.4

 

ELECTION OF DIRECTOR: NIGEL TEN FLEMING, PH.D.

 

Management

 

For

 

For

 

1.5

 

ELECTION OF DIRECTOR: LARRY HSU, PH.D.

 

Management

 

For

 

For

 

1.6

 

ELECTION OF DIRECTOR: MICHAEL MARKBREITER

 

Management

 

For

 

For

 

1.7

 

ELECTION OF DIRECTOR: MARY K. PENDERGAST, J.D.

 

Management

 

For

 

For

 

1.8

 

ELECTION OF DIRECTOR: PETER R. TERRERI

 

Management

 

For

 

For

 

1.9

 

ELECTION OF DIRECTOR: G. FREDERICK WILKINSON

 

Management

 

For

 

For

 

2.

 

TO APPROVE, BY NON-BINDING VOTE, NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

3.

 

RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

 


 

INCYTE CORPORATION

 

Security

 

45337C102

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

INCY

 

 

 

Meeting Date

 

22-May-2015

Record Date

 

02-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JULIAN C. BAKER

 

 

 

For

 

For

 

 

 

2

JEAN-JACQUES BIENAIME

 

 

 

For

 

For

 

 

 

3

PAUL A. BROOKE

 

 

 

For

 

For

 

 

 

4

PAUL J. CLANCY

 

 

 

For

 

For

 

 

 

5

WENDY L. DIXON

 

 

 

For

 

For

 

 

 

6

PAUL A. FRIEDMAN

 

 

 

For

 

For

 

 

 

7

HERVE HOPPENOT

 

 

 

For

 

For

 

2.

 

TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2015.

 

Management

 

For

 

For

 

 

INFINITY PHARMACEUTICALS, INC.

 

Security

 

45665G303

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

INFI

 

 

 

Meeting Date

 

15-Jun-2015

Record Date

 

20-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: JOSE BASELGA, MD, PHD

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: JEFFREY BERKOWITZ, JD

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: ANTHONY B. EVNIN, PHD

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: GWEN A. FYFE, MD

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: ERIC S. LANDER, PHD

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: ADELENE Q. PERKINS

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: NORMAN C. SELBY

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: IAN F. SMITH

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: MICHAEL C. VENUTI, PHD

 

Management

 

For

 

For

 

2

 

TO APPROVE AN AMENDMENT TO THE 2010 STOCK INCENTIVE PLAN TO RESERVE AN ADDITIONAL 2,300,000 SHARES OF COMMON STOCK FOR ISSUANCE THEREUNDER.

 

Management

 

For

 

For

 

3

 

TO APPROVE AN AMENDMENT TO THE 2013 EMPLOYEE STOCK PURCHASE PLAN TO RESERVE AN ADDITIONAL 150,000 SHARES OF COMMON STOCK FOR ISSUANCE THEREUNDER.

 

Management

 

For

 

For

 

4

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE 2015 FISCAL YEAR.

 

Management

 

For

 

For

 

 


 

INSIGHTRA MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

4-Dec-2014

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

AMENDMENT TO OPTION PLAN

 

Management

 

For

 

For

 

2

 

OMNIBUS RESOLUTION

 

Management

 

For

 

For

 

 

INSIGHTRA MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

21-May-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

CONSENT TO INCREASE IN AUTHORIZED SHARES, ISSUANCE OF SHARES AND WAIVER OF ANTI-DILUTION

 

Management

 

For

 

For

 

 

INSIGHTRA MEDICAL, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

21-May-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

DEBT FINANCING

 

Management

 

For

 

For

 

2

 

CERTIFICATE OF AMENDMENT

 

Management

 

For

 

For

 

3

 

AUTHORIZATION OF SALE OF SERIES C-2 PREFERRED STOCK

 

Management

 

For

 

For

 

4

 

GENERAL AUTHORIZING RESOLUTIONS

 

Management

 

For

 

For

 

 

INTELLIPHARMACEUTICS INTERNATIONAL INC.

 

Security

 

458173101

 

 

 

Meeting Type

 

Annual/Special

Ticker Symbol

 

IPCI

 

 

 

Meeting Date

 

21-Apr-2015

Record Date

 

6-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

ELECTION OF DIRECTORS

 

Management

 

For

 

For

 

2

 

REAPPOINTMENT OF DELOITTE LLP

 

Management

 

For

 

For

 

3

 

RESOLUTION APPROVING ALL UNALLOCATED OPTIONS, RIGHTS AND ENTITLEMENTS UNDER THE COMPANY’S STOCK OPTION PLAN

 

Management

 

For

 

For

 

 


 

IRONWOOD PHARMACEUTICALS, INC.

 

Security

 

46333X108

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

IRWD

 

 

 

Meeting Date

 

03-Jun-2015

Record Date

 

10-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

GEORGE H. CONRADES

 

 

 

For

 

For

 

 

 

2

L.S. OLANOFF, M.D., PHD

 

 

 

For

 

For

 

 

 

3

DOUGLAS E WILLIAMS, PHD

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2015

 

Management

 

For

 

For

 

 

KARYOPHARM THERAPEUTICS INC.

 

Security

 

48576U106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

KPTI

 

 

 

Meeting Date

 

22-May-2015

Record Date

 

26-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

D.R. PAKIANATHAN, PH.D.

 

 

 

For

 

For

 

 

 

2

KENNETH E. WEG

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

 


 

KYTHERA BIOPHARMACEUTICALS, INC.

 

Security

 

501570105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

KYTH

 

 

 

Meeting Date

 

02-Jun-2015

Record Date

 

06-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

KEITH R. LEONARD, JR.

 

 

 

For

 

For

 

 

 

2

HOLLINGS C. RENTON III

 

 

 

For

 

For

 

 

 

3

CAMILLE SAMUELS

 

 

 

For

 

For

 

2

 

APPROVAL OF THE KYTHERA BIOPHARMACEUTICALS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN

 

Management

 

For

 

For

 

3

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2015

 

Management

 

For

 

For

 

 

MACROGENICS, INC.

 

Security

 

556099109

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

MGNX

 

 

 

Meeting Date

 

20-May-2015

Record Date

 

31-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

KENNETH GALBRAITH

 

 

 

For

 

For

 

 

 

2

DAVID STUMP, M.D.

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

 

MAGELLAN BIOSCIENCES, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

7-Nov-2014

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

STOCK PURCHASE AND RELEASE AGREEMENT

 

Management

 

For

 

For

 

2

 

IMPACT OF THE REDEMPTION ON THE SALE PARTICIPATION PROGRAM

 

Management

 

For

 

For

 

3

 

GENERAL AUTHORIZATION

 

Management

 

For

 

For

 

 


 

MAGELLAN BIOSCIENCES, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

N/A

Record Date

 

N/A

 

 

 

 

 

19-Nov-2014

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

STOCK PURCHASE AND RELEASE AGREEMENT

 

Management

 

For

 

For

 

 

MEI PHARMA, INC.

 

Security

 

55279B202

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

MEIP

 

 

 

Meeting Date

 

03-Dec-2014

Record Date

 

03-Oct-2014

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

LEAH RUSH CANN

 

 

 

For

 

For

 

 

 

2

DANIEL P. GOLD, PH.D.

 

 

 

For

 

For

 

 

 

3

KEVAN E. CLEMENS, PH.D.

 

 

 

For

 

For

 

2.

 

TO APPROVE THE AMENDED AND RESTATED MEI PHARMA, INC. 2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN (THE “2008 EQUITY PLAN”) TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK THAT MAY BE SUBJECT TO AWARDS, INCREASE THE NUMBER OF SHARES WITH RESPECT TO WHICH GRANTS MAY BE MADE TO ANY INDIVIDUAL DURING ANY CALENDAR ...(DUE TO SPACE LIMITS, SEE PROXY STATEMENT FOR FULL PROPOSAL).

 

Management

 

Against

 

Against

 

3.

 

RATIFICATION OF APPOINTMENT OF BDO USA, LLP, AS MEI PHARMA, INC.’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING JUNE 30, 2015.

 

Management

 

For

 

For

 

4.

 

TO APPROVE ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS (SAY-ON-PAY VOTE).

 

Management

 

Against

 

Against

 

 


 

MERRIMACK PHARMACEUTICALS, INC.

 

Security

 

590328100

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

MACK

 

 

 

Meeting Date

 

12-May-2015

Record Date

 

18-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT J. MULROY

 

 

 

For

 

For

 

 

 

2

GARY L. CROCKER

 

 

 

For

 

For

 

 

 

3

GORDON J. FEHR

 

 

 

For

 

For

 

 

 

4

VIVIAN S. LEE, M.D. PHD

 

 

 

For

 

For

 

 

 

5

JOHN MENDELSOHN, M.D.

 

 

 

For

 

For

 

 

 

6

ULRIK B. NIELSEN, PH.D.

 

 

 

For

 

For

 

 

 

7

MICHAEL E. PORTER, PHD

 

 

 

For

 

For

 

 

 

8

JAMES H. QUIGLEY

 

 

 

For

 

For

 

 

 

9

RUSSELL T. RAY

 

 

 

For

 

For

 

2.

 

TO APPROVE, ON AN ADVISORY BASIS, OUR EXECUTIVE COMPENSATION.

 

Management

 

For

 

For

 

3.

 

TO RECOMMEND, ON AN ADVISORY BASIS,THE FREQUENCY OF FUTURE ADVISORY VOTES ON OUR EXECUTIVE COMPENSATION.

 

Management

 

1 Year

 

For

 

4.

 

TO RATIFY THE SELECTION OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

 

MOMENTA PHARMACEUTICALS, INC.

 

Security

 

60877T100

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

MNTA

 

 

 

Meeting Date

 

09-Jun-2015

Record Date

 

14-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JOHN K. CLARKE

 

 

 

For

 

For

 

 

 

2

JAMES R. SULAT

 

 

 

For

 

For

 

 

 

3

CRAIG A. WHEELER

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

TO APPROVE, ON AN ADVISORY (NON-BINDING) BASIS, THE COMPENSATION OF THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE 2013 INCENTIVE AWARD PLAN.

 

Management

 

For

 

For

 

 


 

MYLAN INC.

 

Security

 

628530107

 

 

 

Meeting Type

 

Special

Ticker Symbol

 

MYL

 

 

 

Meeting Date

 

29-Jan-2015

Record Date

 

23-Dec-2014

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

APPROVAL OF THE AMENDED AND RESTATED BUSINESS TRANSFER AGREEMENT AND PLAN OF MERGER, DATED AS OF NOVEMBER 4, 2014, BY AND AMONG MYLAN, INC. (“MYLAN”), NEW MOON B.V., MOON OF PA INC., AND ABBOTT LABORATORIES (THE “BUSINESS TRANSFER AGREEMENT”).

 

Management

 

For

 

For

 

2.

 

APPROVAL, ON A NON-BINDING ADVISORY BASIS, OF THE SPECIFIED COMPENSATORY ARRANGEMENTS BETWEEN MYLAN AND ITS NAMED EXECUTIVE OFFICERS RELATING TO THE MERGER AND THE OTHER TRANSACTIONS CONTEMPLATED BY THE BUSINESS TRANSFER AGREEMENT.

 

Management

 

For

 

For

 

3.

 

ADJOURNMENT OF THE SPECIAL MEETING, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES TO APPROVE THE BUSINESS TRANSFER AGREEMENT.

 

Management

 

For

 

For

 

 

NEUROCRINE BIOSCIENCES, INC.

 

Security

 

64125C109

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

NBIX

 

 

 

Meeting Date

 

28-May-2015

Record Date

 

01-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

W. THOMAS MITCHELL

 

 

 

For

 

For

 

 

 

2

JOSEPH A. MOLLICA

 

 

 

For

 

For

 

 

 

3

WILLIAM H. RASTETTER

 

 

 

For

 

For

 

2.

 

ADVISORY VOTE TO APPROVE THE COMPENSATION PAID TO THE COMPANY’S NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO THE COMPANY’S 2011 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK RESERVED FOR ISSUANCE THEREUNDER FROM 8,500,000 TO 13,500,000.

 

Management

 

For

 

For

 

4.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

 


 

NEUROVANCE, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

11-Aug-2014

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

2

 

AMENDMENT NO. 3 TO 2011 EQUITY INCENTIVE PLAN

 

Management

 

For

 

For

 

 

NEUROVANCE, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

17-Feb-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

APPOINTMENT OF BOARD OF DIRECTORS

 

Management

 

For

 

For

 

 


 

NEUROVANCE, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

4-Mar-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

REVERSE SPLIT AND AMENDMENT OF CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

2

 

AMENDMENT TO THE 2011 EQUITY INCENTIVE PLAN

 

Management

 

For

 

For

 

3

 

$11M SERIES A1 EXTENSION FINANCING

 

Management

 

For

 

For

 

 

NEUROVANCE, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

5-Jun-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

$6.5M SERIES A1 EXTENSION FINANCING

 

Management

 

For

 

For

 

2

 

AMENDMENT NO. 1 TO THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION

 

Management

 

For

 

For

 

3

 

AMENDMENT TO THE 2011 EQUITY INCENTIVE PLAN

 

Management

 

For

 

For

 

 

NEUROVANCE, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

25-Jun-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

ENGAGEMENT LETTER WITH BTIG LLC

 

Management

 

For

 

For

 

 


 

ONCOGENEX PHARMACEUTICALS, INC

 

Security

 

68230A106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

OGXI

 

 

 

Meeting Date

 

21-May-2015

Record Date

 

31-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

SCOTT CORMACK

 

 

 

For

 

For

 

 

 

2

NEIL CLENDENINN

 

 

 

For

 

For

 

 

 

3

JACK GOLDSTEIN

 

 

 

For

 

For

 

 

 

4

MARTIN MATTINGLY

 

 

 

For

 

For

 

 

 

5

STEWART PARKER

 

 

 

For

 

For

 

 

 

6

DAVID SMITH

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO OUR 2010 PERFORMANCE INCENTIVE PLAN THAT WILL INCREASE THE TOTAL SHARES OF COMMON STOCK AVAILABLE FOR ISSUANCE UNDER THE 2010 PERFORMANCE INCENTIVE PLAN FROM 2,800,000 TO 4,300,000.

 

Management

 

For

 

For

 

4.

 

TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE OUR AUTHORIZED SHARES OF COMMON STOCK FROM 50,000,000 TO 75,000,000.

 

Management

 

For

 

For

 

 


 

PERRIGO COMPANY PLC

 

Security

 

G97822103

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

PRGO

 

 

 

Meeting Date

 

04-Nov-2014

Record Date

 

05-Sep-2014

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1A.

 

ELECTION OF DIRECTOR: LAURIE BRLAS

 

Management

 

For

 

For

 

1B.

 

ELECTION OF DIRECTOR: GARY M. COHEN

 

Management

 

For

 

For

 

1C.

 

ELECTION OF DIRECTOR: JACQUALYN A. FOUSE

 

Management

 

For

 

For

 

1D.

 

ELECTION OF DIRECTOR: DAVID T. GIBBONS

 

Management

 

For

 

For

 

1E.

 

ELECTION OF DIRECTOR: RAN GOTTFRIED

 

Management

 

For

 

For

 

1F.

 

ELECTION OF DIRECTOR: ELLEN R. HOFFING

 

Management

 

For

 

For

 

1G.

 

ELECTION OF DIRECTOR: MICHAEL J. JANDERNOA

 

Management

 

For

 

For

 

1H.

 

ELECTION OF DIRECTOR: GARY K. KUNKLE, JR.

 

Management

 

For

 

For

 

1I.

 

ELECTION OF DIRECTOR: HERMAN MORRIS, JR.

 

Management

 

For

 

For

 

1J.

 

ELECTION OF DIRECTOR: DONAL O’CONNOR

 

Management

 

For

 

For

 

1K.

 

ELECTION OF DIRECTOR: JOSEPH C. PAPA

 

Management

 

For

 

For

 

2.

 

RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT AUDITORS FOR FISCAL YEAR 2015

 

Management

 

For

 

For

 

3.

 

AN ADVISORY VOTE TO APPROVE THE COMPANY’S EXECUTIVE COMPENSATION

 

Management

 

For

 

For

 

4.

 

AUTHORIZE PERRIGO COMPANY PLC AND/OR ANY SUBSIDIARY OF PERRIGO COMPANY PLC TO MAKE MARKET PURCHASES OF PERRIGO COMPANY PLC’S ORDINARY SHARES

 

Management

 

For

 

For

 

5.

 

DETERMINE THE REISSUE PRICE RANGE FOR PERRIGO COMPANY PLC TREASURY SHARES

 

Management

 

For

 

For

 

6.

 

APPROVE THE CREATION OF DISTRIBUTABLE RESERVES BY REDUCING SOME OR ALL OF PERRIGO COMPANY PLC’S SHARE PREMIUM

 

Management

 

For

 

For

 

 


 

PHT CORPORATION

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

12-Mar-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

APPROVAL OF CERTAIN COMPENSATORY PAYMENTS PURSUANT TO SECTION 280G OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED

 

Management

 

For

 

For

 

 

PHT CORPORATION

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

19-Feb-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

APPROVAL OF MERGER

 

Management

 

For

 

For

 

2

 

DISSENTER AND APPRAISAL RIGHTS

 

Management

 

For

 

For

 

3

 

EXERCISE OF DRAG-ALONG RIGHT

 

Management

 

For

 

For

 

4

 

TERMINATION OF STOCKHOLDER AGREEMENTS

 

Management

 

For

 

For

 

5

 

GENERAL

 

Management

 

For

 

For

 

 


 

RECEPTOS INC

 

Security

 

756207106

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

RCPT

 

 

 

Meeting Date

 

28-May-2015

Record Date

 

02-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

RICHARD A. HEYMAN, PH.D

 

 

 

For

 

For

 

 

 

2

WILLIAM H RASTETTER PHD

 

 

 

For

 

For

 

 

 

3

MARY SZELA

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO OUR EMPLOYEE STOCK PURCHASE PLAN.

 

Management

 

For

 

For

 

 

REGENERON PHARMACEUTICALS, INC.

 

Security

 

75886F107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

REGN

 

 

 

Meeting Date

 

12-Jun-2015

Record Date

 

16-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

CHARLES A. BAKER

 

 

 

For

 

For

 

 

 

2

ARTHUR F. RYAN

 

 

 

For

 

For

 

 

 

3

GEORGE L. SING

 

 

 

For

 

For

 

 

 

4

MARC TESSIER-LAVIGNE

 

 

 

For

 

For

 

2

 

RATIFICATION OF THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3

 

APPROVAL OF THE REGENERON PHARMACEUTICALS, INC. CASH INCENTIVE BONUS PLAN.

 

Management

 

For

 

For

 

4

 

APPROVAL OF AN AMENDMENT TO THE COMPANY’S CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF CAPITAL STOCK AND COMMON STOCK.

 

Management

 

For

 

For

 

5

 

NONBINDING SHAREHOLDER PROPOSAL RELATING TO PROXY ACCESS, IF PROPERLY PRESENTED.

 

Shareholder

 

Against

 

For

 

 


 

SAGE THERAPEUTICS INC.

 

Security

 

78667J108

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

SAGE

 

 

 

Meeting Date

 

28-May-2015

Record Date

 

02-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

STEVEN PAUL, M.D.

 

 

 

For

 

For

 

 

 

2

ROBERT T. NELSEN

 

 

 

For

 

For

 

2

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015

 

Management

 

For

 

For

 

3

 

TO RATIFY THE 2014 STOCK OPTION AND INCENTIVE PLAN.

 

Management

 

For

 

For

 

 

SAGENT PHARMACEUTICALS, INC

 

Security

 

786692103

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

SGNT

 

 

 

Meeting Date

 

09-Jun-2015

Record Date

 

15-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

MICHAEL FEKETE*

 

 

 

For

 

For

 

 

 

2

SHLOMO YANAI*

 

 

 

For

 

For

 

 

 

3

ROBERT FLANAGAN#

 

 

 

For

 

For

 

2.

 

TO RATIFY THE RETENTION OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

AN ADVISORY VOTE TO APPROVE THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS.

 

Management

 

For

 

For

 

 


 

SORRENTO THERAPEUTICS, INC

 

Security

 

83587F202

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

SRNE

 

 

 

Meeting Date

 

04-Jun-2015

Record Date

 

13-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

HENRY JI, PH.D.

 

 

 

For

 

For

 

 

 

2

WILLIAM MARTH

 

 

 

For

 

For

 

 

 

3

KIM D. JANDA, PH.D.

 

 

 

For

 

For

 

 

 

4

DOUGLAS EBERSOLE

 

 

 

For

 

For

 

 

 

5

JAISIM SHAH

 

 

 

For

 

For

 

 

 

6

DAVID H. DEMING

 

 

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF MAYER HOFFMAN MCCANN P.C. AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

TO CONSIDER AND VOTE UPON, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS AS DISCLOSED IN THIS PROXY STATEMENT PURSUANT TO THE COMPENSATION DISCLOSURE RULES OF THE SECURITIES AND EXCHANGE COMMISSION.

 

Management

 

For

 

For

 

4.

 

TO CONSIDER AND VOTE UPON, ON AN ADVISORY BASIS, WHETHER THE STOCKHOLDER VOTE TO APPROVE THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS AS REQUIRED BY SECTION 14A(A)(2) OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, SHOULD OCCUR EVERY ONE, TWO OR THREE YEARS.

 

Management

 

3 Years

 

For

 

 


 

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

 

Security

 

881624209

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

TEVA

 

 

 

Meeting Date

 

30-Jul-2014

Record Date

 

23-Jun-2014

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1A.

 

TO APPOINT DAN PROPPER AS DIRECTOR, TO SERVE UNTIL THE 2017 ANNUAL MEETING OF SHAREHOLDERS.

 

Management

 

For

 

For

 

1B.

 

TO APPOINT ORY SLONIM AS DIRECTOR, TO SERVE UNTIL THE 2017 ANNUAL MEETING OF SHAREHOLDERS.

 

Management

 

For

 

For

 

2A.

 

TO APPOINT MR. JOSEPH (YOSSI) NITZANI TO SERVE AS A STATUTORY INDEPENDENT DIRECTOR FOR AN ADDITIONAL TERM OF THREE YEARS, FOLLOWING THE EXPIRATION OF HIS SECOND TERM OF SERVICE ON SEPTEMBER 25, 2014, AND TO APPROVE HIS REMUNERATION AND BENEFITS.

 

Management

 

For

 

For

 

2B.

 

TO APPOINT MR. JEAN-MICHEL HALFON TO SERVE AS A STATUTORY INDEPENDENT DIRECTOR FOR A TERM OF THREE YEARS, COMMENCING FOLLOWING MEETING, AND TO APPROVE HIS REMUNERATION & BENEFITS.

 

Management

 

For

 

For

 

3A.

 

TO APPROVE THE ANNUAL CASH BONUS OBJECTIVES FOR THE COMPANY’S PRESIDENT & CHIEF EXECUTIVE OFFICER FOR 2014 AND GOING FORWARD.

 

Management

 

For

 

For

 

3B.

 

TO APPROVE ANNUAL EQUITY AWARDS FOR THE COMPANY’S PRESIDENT AND CHIEF EXECUTIVE OFFICER FOR EACH YEAR COMMENCING IN 2015.

 

Management

 

For

 

For

 

4.

 

TO APPROVE THE PURCHASE OF DIRECTORS’ AND OFFICERS’ LIABILITY INSURANCE WITH ANNUAL COVERAGE OF UP TO $600 MILLION.

 

Management

 

For

 

For

 

5.

 

TO APPOINT KESSELMAN & KESSELMAN, A MEMBER OF PRICEWATERHOUSECOOPERS INTERNATIONAL LTD., AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM UNTIL THE 2015 ANNUAL MEETING OF SHAREHOLDERS.

 

Management

 

For

 

For

 

 


 

THERAPEUTICSMD, INC.

 

Security

 

88338N107

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

TXMD

 

 

 

Meeting Date

 

11-Jun-2015

Record Date

 

22-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

TOMMY G. THOMPSON

 

 

 

For

 

For

 

 

 

2

ROBERT G. FINIZIO

 

 

 

For

 

For

 

 

 

3

JOHN C.K. MILLIGAN, IV

 

 

 

For

 

For

 

 

 

4

BRIAN BERNICK

 

 

 

For

 

For

 

 

 

5

J. MARTIN CARROLL

 

 

 

For

 

For

 

 

 

6

COOPER C. COLLINS

 

 

 

For

 

For

 

 

 

7

ROBERT V. LAPENTA, JR.

 

 

 

For

 

For

 

 

 

8

JULES A. MUSING

 

 

 

For

 

For

 

 

 

9

ANGUS C. RUSSELL

 

 

 

For

 

For

 

 

 

10

NICHOLAS SEGAL

 

 

 

For

 

For

 

2.

 

TO APPROVE, ON A NON-BINDING ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2014 (SAY-ON-PAY).

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE APPOINTMENT OF GRANT THORNTON LLP, AN INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, AS THE INDEPENDENT AUDITOR OF OUR COMPANY FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

4.

 

TO APPROVE AN AMENDMENT TO OUR AMENDED AND RESTATED ARTICLES OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF OUR COMMON STOCK FROM 250,000,000 SHARES TO 350,000,000 SHARES.

 

Management

 

For

 

For

 

 


 

TRILLIUM THERAPEUTICS INC.

 

Security

 

89620X506

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

TRIL

 

 

 

Meeting Date

 

27-May-2015

Record Date

 

22-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

01

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

LUKE BESHAR

 

 

 

For

 

For

 

 

 

2

HENRY FRIESEN

 

 

 

For

 

For

 

 

 

3

ROBERT KIRKMAN

 

 

 

For

 

For

 

 

 

4

MICHAEL MOORE

 

 

 

For

 

For

 

 

 

5

THOMAS REYNOLDS

 

 

 

For

 

For

 

 

 

6

NICLAS STIERNHOLM

 

 

 

For

 

For

 

 

 

7

CALVIN STILLER

 

 

 

For

 

For

 

02

 

APPOINTMENT OF ERNST & YOUNG LLP, CHARTERED PROFESSIONAL ACCOUNTANTS, LICENSED PUBLIC ACCOUNTANTS, AS AUDITORS OF THE CORPORATION FOR THE ENSUING YEAR AND AUTHORIZING THE DIRECTORS TO FIX THEIR REMUNERATION.

 

Management

 

For

 

For

 

 

VENITI, INC.

 

Security

 

N/A

 

 

 

Meeting Type

 

Written Consent

Ticker Symbol

 

N/A

 

 

 

Meeting Date

 

21-Apr-2015

Record Date

 

N/A

 

 

 

 

 

 

 

Item

 

Proposal

 

Type

 

Vote

 

For/Against
Management

 

1

 

APPROVE REPURCHASE AGREEMENT AND WAIVER OF FIRST REFUSAL AND CO-SALE AGREEMENT

 

Management

 

For

 

For

 

 


 

VERASTEM INC

 

Security

 

92337C104

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

VSTM

 

 

 

Meeting Date

 

08-May-2015

Record Date

 

26-Mar-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

ROBERT FORRESTER

 

 

 

For

 

For

 

 

 

2

HENRI TERMEER

 

 

 

For

 

For

 

 

 

3

CHRISTOPH WESTPHAL M.D.

 

 

 

For

 

For

 

2.

 

TO RATIFY THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2015.

 

Management

 

For

 

For

 

 

VERTEX PHARMACEUTICALS INCORPORATED

 

Security

 

92532F100

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

VRTX

 

 

 

Meeting Date

 

04-Jun-2015

Record Date

 

10-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

JEFFREY M. LEIDEN

 

 

 

For

 

For

 

 

 

2

BRUCE I. SACHS

 

 

 

For

 

For

 

 

 

3

SANGEETA N. BHATIA

 

 

 

For

 

For

 

2.

 

AMENDMENT TO OUR ARTICLES OF ORGANIZATION THAT INCREASES THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE FROM 300 MILLION TO 500 MILLION.

 

Management

 

For

 

For

 

3.

 

AMENDMENT AND RESTATEMENT OF OUR 2013 STOCK AND OPTION PLAN THAT, AMONG OTHER THINGS, INCREASES THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE UNDER THE PLAN BY 7.8 MILLION SHARES.

 

Management

 

For

 

For

 

4.

 

RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

5.

 

ADVISORY VOTE ON OUR NAMED EXECUTIVE OFFICER COMPENSATION.

 

Management

 

For

 

For

 

6.

 

SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REGARDING A PROXY ACCESS BY-LAW.

 

Shareholder

 

Against

 

For

 

7.

 

SHAREHOLDER PROPOSAL, IF PROPERLY PRESENTED AT THE MEETING, REQUESTING A REPORT ON SPECIALTY DRUG PRICES.

 

Shareholder

 

Against

 

For

 

 


 

XENCOR INC

 

Security

 

98401F105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

XNCR

 

 

 

Meeting Date

 

09-Jun-2015

Record Date

 

14-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

DR. BRUCE L.A. CARTER

 

 

 

For

 

For

 

 

 

2

ROBERT BALTERA, JR

 

 

 

For

 

For

 

 

 

3

DR. BASSIL I. DAHIYAT

 

 

 

For

 

For

 

 

 

4

JONATHAN FLEMING

 

 

 

For

 

For

 

 

 

5

KURT GUSTAFSON

 

 

 

For

 

For

 

 

 

6

DR. A. BRUCE MONTGOMERY

 

 

 

For

 

For

 

 

 

7

JOHN S. STAFFORD III

 

 

 

For

 

For

 

2.

 

PROPOSAL TO RATIFY BDO USA, LLP AS THE INDEPENDENT PUBLIC ACCOUNTING FIRM FOR 2015.

 

Management

 

For

 

For

 

 

ZAFGEN INC

 

Security

 

98885E103

 

 

 

Meeting Type

 

Annual

 

Ticker Symbol

 

ZFGN

 

 

 

Meeting Date

 

25-Jun-2015

 

Record Date

 

27-Apr-2015

 

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.1

 

ELECTION OF DIRECTOR: BRUCE BOOTH, PH.D.

 

Management

 

For

 

For

 

1.2

 

ELECTION OF DIRECTOR: AVI GOLDBERG

 

Management

 

For

 

For

 

2.

 

TO RATIFY THE APPOINTMENT OF PRICEWATERHOUSECOOPERS LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2015

 

Management

 

For

 

For

 

3.

 

TO RATIFY THE 2014 STOCK OPTION AND INCENTIVE PLAN

 

Management

 

For

 

For

 

 


 

ZOGENIX, INC.

 

Security

 

98978L105

 

 

 

Meeting Type

 

Annual

Ticker Symbol

 

ZGNX

 

 

 

Meeting Date

 

18-Jun-2015

Record Date

 

21-Apr-2015

 

 

 

 

 

 

 

Item

 

Proposal

 

Proposed
by

 

Vote

 

For/Against
Management

 

1.

 

DIRECTOR

 

Management

 

 

 

 

 

 

 

1

J.B. BREITMEYER, MD PHD

 

 

 

For

 

For

 

 

 

2

STEPHEN J. FARR, PH.D.

 

 

 

For

 

For

 

2.

 

RATIFICATION OF THE SELECTION OF ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2015.

 

Management

 

For

 

For

 

3.

 

TO APPROVE AN AMENDMENT TO OUR FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION, AS AMENDED, TO EFFECT A REVERSE STOCK SPLIT OF OUR OUTSTANDING COMMON STOCK AT AN EXCHANGE RATIO OF 1-FOR-8, AND A CHANGE IN THE NUMBER OF AUTHORIZED SHARES OF OUR COMMON STOCK TO 50,000,000 SHARES, SUBJECT TO THE BOARD OF DIRECTORS’ AUTHORITY TO ABANDON SUCH AMENDMENT.

 

Management

 

For

 

For

 

 


 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

(Registrant)

Tekla Life Sciences Investors

 

 

By (Signature and Title)*

 

 

 

 

/s/ Daniel R. Omstead

 

(Daniel R. Omstead, President)

 

 

Date

8/28/15

 

*Print the name and title of each signing officer under his or her signature.

 

2